coronavirus
studi
detail
date
describ
three
four
uniqu
major
structur
protein
predomin
phosphoryl
nucleocapsid
n
protein
molecular
weight
rang
associ
nonseg
positivestrand
rna
genom
two
major
virusencod
envelop
protein
transmembran
glycoprotein
approxim
molwt
act
matrix
protein
e
peplom
protein
glycoprotein
molwt
make
larg
surfac
project
viru
peplomer
protein
often
posttranst
cleav
hostcel
proteas
two
subunit
molwt
glycoprotein
respons
viru
attach
cell
membran
fusion
elicit
product
virusneutr
antibodi
hemaggtutinin
hemagglutin
mammalian
coronavirus
made
addit
glycoprotein
molwt
compriz
disulfidelink
subunit
mani
enter
coronavirus
difficult
grow
tissu
cultur
consequ
littl
known
molecular
antigen
structur
turkey
enter
coronaviru
tcv
recogn
one
major
caus
agent
epidem
diarrhea
turkey
poult
exampl
group
previou
attempt
adapt
tcv
isol
differ
type
cultur
chicken
turkey
embryon
cell
unsuccess
prototyp
minnesota
strain
maintain
oral
inocul
intestin
infect
oneday
old
turkey
poult
inocul
amniot
caviti
embryon
turkey
hen
egg
previou
studi
morpholog
biolog
activ
eggadapt
tcv
isol
reveal
presenc
two
morpholog
distinct
type
peplom
surfac
tcv
virion
viru
also
possess
hemagglutin
activ
low
quantiti
materi
obtain
end
prepar
pure
viru
residu
hostcel
contamin
protein
eggadapt
viru
rais
difficulti
distinguish
specif
viral
compon
degrad
host
protein
tcv
isol
purifi
intestin
content
turkey
embryo
resolv
four
seven
major
polypeptid
rang
molecular
weight
identifi
viral
compon
basi
reactiv
specif
antisera
exact
natur
polypeptid
locat
tcv
virion
remain
determin
report
den
polypeptid
structur
tissu
cultureadapt
tcv
isol
identifi
three
major
glycoprotein
correspond
matrix
peplom
hemagglutinin
tcv
virion
radiolabel
ad
glycosyl
inhibitor
viru
product
partial
proteas
digest
virion
electron
microscopi
purifi
proteasetr
viru
allow
us
obtain
inform
morpholog
characterist
avian
coronaviru
prototyp
eggadapt
minnesota
strain
tcv
obtain
dr
b
pomeroy
colleg
veterinari
medicin
univ
minnesota
st
paul
mn
use
studi
viru
serial
propag
presenc
trypsin
confluent
monolay
human
rectal
tumor
cell
line
previous
describ
growth
viru
measur
titrat
clarifi
cultur
medium
use
endpoint
dilut
procedur
calcul
tcid
accord
reed
muench
viral
stock
prepar
passag
infect
cell
multipl
tcid
per
cell
viru
purifi
supernat
fluid
infect
cell
cultur
differenti
isopycn
ultracentrifug
sucros
gradient
previous
describ
purifi
viru
sediment
buoyant
densiti
gml
determin
coincident
peak
hemagglutin
activ
optic
densiti
rim
collect
viru
dilut
tb
pellet
ultracentrifug
rpm
beckman
sw
rotor
viral
materi
gentli
suspend
tb
divid
aliquot
quickli
frozen
protein
concentr
purifi
viral
suspens
determin
method
bradford
hemagglutin
assay
perform
use
rat
erythrocyt
describ
previous
aliquot
purifi
viru
incub
ggml
tgml
either
trypsin
achymotrypsin
pronas
tmen
mm
trismal
mm
edta
mm
ph
buffer
rain
case
trypsin
treatment
digest
reaction
stop
ad
equal
amount
soybean
trypsin
inhibitor
incub
rain
treatment
bromelain
purifi
viru
incub
mgml
enzym
tmem
contain
mm
dithiothreitol
h
enzymat
treatment
viru
immedi
subject
isopycn
centrifug
test
residu
ha
activ
analyz
sdspage
antitcv
hyperimmun
serum
obtain
immun
rabbit
purifi
eggadapt
viru
specif
antiserum
confirm
immunoelectron
microscopi
hemagglutin
inhibit
confluent
monolay
cell
grown
cruztissu
cultur
flask
corn
infect
multipl
tcid
adsorpt
viru
h
monolay
incub
serumfre
medium
contain
uml
trypsin
tunicamycin
concentr
tgml
sodium
monensin
concentr
gm
ad
mainten
media
glycosylationinhibit
experi
h
postinfect
pi
medium
remov
ml
appropri
medium
without
glycosyl
inhibitor
radioisotop
compound
ad
viral
protein
label
addit
methionin
gci
amino
acid
mixtur
llysin
lleucin
lalanin
per
flask
methioninefre
rpmi
medium
mem
contain
percent
normal
concentr
leucin
lysin
respect
viral
glycoprotein
label
glucosamin
hydrochlorid
gciml
mem
contain
per
cent
normal
concentr
glucos
supernat
contain
radiolabel
viru
harvest
h
pi
immunoprecipit
experi
purifi
radiolabel
proteasetr
untreat
viru
done
essenti
describ
orvetl
et
al
use
rabbit
antitcv
hyperimmun
serum
h
incub
room
temperatur
immun
complex
adsorb
protein
asepharos
pharmacia
desorb
denatur
prior
electrophoresi
boil
min
sampl
buffer
western
immunoblot
assay
done
accord
deregt
babiuk
discontinu
buffer
gel
system
laemmli
use
sampl
mix
equal
volum
doubl
strength
sampl
buffer
without
per
cent
boil
clarifi
x
g
electrophoresi
percent
sdspolyacrylamid
slab
gel
previous
describ
high
low
molecular
weight
marker
protein
marker
protein
run
gel
allow
molecular
weight
estim
viral
protein
polypeptid
band
reveal
either
silver
stain
fluorographi
amplifi
amersham
dri
gel
autoradiograph
kodak
xomat
rp
film
concentr
gradientpurifi
proteasetr
virion
neg
stain
sodium
phosphotungst
ph
examin
em
describ
previous
previou
studi
cell
cultiv
minnesota
strain
tcv
reveal
effect
product
viru
cell
provid
trypsin
ad
cultur
medium
high
yield
viral
infect
rang
recov
less
success
passag
ha
titer
rose
also
number
passag
rat
erythrocyt
rang
data
repres
viru
purif
experi
tabl
show
reduct
volum
greater
decreas
total
protein
recoveri
viru
infect
procedur
allow
prepar
mg
approxim
purifi
viru
x
cell
specif
infect
averag
x
tcid
protein
three
visibl
band
obtain
follow
centrifug
continu
sucros
gradient
infect
ha
activ
restrict
band
correspond
buoyant
fig
correspond
fraction
contain
viral
particl
morpholog
consist
coronavirus
major
viral
particl
possess
surfac
project
two
distinct
size
fig
b
analysi
sdspage
nonreduc
condit
purifi
methionineor
acidslabel
tcv
reveal
consist
least
four
major
two
minor
polypeptid
speci
result
essenti
viru
cultiv
presenc
absenc
trypsin
fig
acid
glucosamin
purifi
viru
electrophores
solubil
sampl
buffer
absenc
presenc
per
cent
acrylamid
concentr
gel
per
cent
posit
molecular
weight
standard
shown
left
glycoprotein
glycosyl
polypeptid
molwt
excess
major
compon
estim
possess
molecular
weight
two
minor
compon
molwt
respect
lane
molwt
polypeptid
characterist
observ
broad
band
group
close
migrat
band
addit
three
addit
polypeptid
speci
molwt
migrat
band
vari
intens
irregularli
detect
three
polypeptid
molwt
speci
could
resolv
immunoprecipit
obtain
incub
antitcv
rabbit
hyperimmun
serum
fig
c
label
glucosamin
reveal
molwt
speci
glycosyl
henc
design
gp
gp
fig
lane
condit
speci
usual
reveal
major
band
addit
glycosyl
polypeptid
design
fig
molwt
excess
identifi
glucosaminelabel
viru
presenc
gp
could
longer
detect
instead
new
glycosyl
polypeptid
estim
molwt
observ
fig
lane
result
also
confirm
immunoprecipit
data
shown
western
immunoblot
experi
fig
suggest
gp
disulfidelink
dimer
two
smaller
speci
determin
locat
tcv
glycoprotein
aliquot
purifi
viru
stock
mockdigest
digest
pronas
trypsin
bromelain
repurifi
isopycn
sediment
analyz
em
sdspage
fig
proteasetr
tcv
also
test
residu
hemagglutin
activ
tabl
virion
treat
pronas
concentr
mgml
lost
hemagglutin
activ
min
tabl
coincident
disappear
highmolecularweight
glycoprotein
gp
gel
fig
examin
em
repurifi
particl
show
rain
digest
fring
small
granular
project
still
present
virion
surfac
digest
p
molwt
polypeptid
predomin
speci
remain
fig
lane
particl
appear
rel
smooth
fig
time
exposur
tcv
pronas
also
transform
viral
envelop
make
permeabl
phosphotungst
result
progress
differ
solubilis
sampl
buffer
without
mockdigest
digestedviru
analyz
electrophoresi
sdspolyacrylamid
slab
gel
viral
protein
reveal
silver
stain
fluorographi
westernimmunoblot
rabbit
antitcv
hyperimmun
serum
electrophoret
profil
radiolabel
tcv
treatment
pronas
mgml
rain
electrophores
absenc
b
electrophoret
profil
silver
stain
tcv
treatment
min
lag
lag
per
ml
trypsin
lag
per
ml
achymotrypsin
treatment
h
mgmt
bromelain
electrophores
absenc
c
immunoblot
tcv
treatment
trypsin
lagml
rain
treatment
bromelain
mg
ml
electrophores
absenc
immunoblot
tcv
treatment
bromelain
h
electrophoresi
nonreduc
reduc
condit
fig
neg
stain
purifi
viral
particl
alter
treatment
proteolyt
enzym
aliquot
purifi
viru
treat
variou
proteas
indic
concentr
repurifi
isopycn
sediment
sucros
gradient
ae
treat
mgml
pronas
min
respect
e
treat
ixgml
trypsin
respect
f
treat
mgml
bromelain
h
arrow
indic
evagin
surfac
viral
particl
appar
intern
tongueshap
structur
small
granular
surfac
project
bar
nrn
type
viral
particl
presenc
inner
fold
viral
envelop
c
n
l
observ
min
exposur
enzym
give
rise
characterist
tonguelik
structur
describ
sever
coronavirus
longer
exposur
min
center
viral
particl
dens
stain
fig
numer
ghostlik
structur
found
incub
hour
either
trypsin
achymotrypsin
concentr
mgml
alter
hemagglutin
activ
c
v
tabl
howev
complet
nearli
complet
dissappear
speci
f
r
gel
c
n
c
n
slight
increas
u
n
f
gp
gp
speci
observ
fig
b
c
structur
glycoprotein
appear
resist
enzym
trypsintr
virion
maintain
type
surfac
project
concentr
lower
lgml
appar
lost
larg
peplom
higher
concentr
fig
r
e
e
n
achymotrypsin
result
appar
enlarg
diamet
tip
larger
project
retain
surfac
f
virion
data
shown
evagin
intern
tongueshap
structur
possess
characterist
clubshap
project
f
outer
e
b
r
n
e
often
observ
follow
treatment
enzym
fig
e
digest
c
v
bromelain
two
hour
alter
hemaggtutin
activ
f
viru
fig
c
lane
treatment
also
left
intern
protein
intact
reduc
amount
concomit
disappear
molwt
speci
fig
although
decreas
amount
ofp
notic
silverstain
gel
h
treatment
enzym
fig
b
lane
still
strongli
evid
follow
westernimmunoblot
antitcv
serum
well
gp
speci
fig
lane
examin
em
repurifi
particl
treatment
bromelain
h
show
progress
loss
larg
bulbou
peplom
persist
small
granular
project
without
appar
damag
particl
fig
longer
exposur
enzym
h
viral
particl
possess
small
granular
project
recov
sucros
gradient
fraction
buoyant
densiti
correspond
origin
viru
numer
ghostlik
membran
structur
observ
fraction
correspond
sucros
densiti
gml
viru
purifi
supernat
fluid
tcvinfect
cell
cultur
cultiv
presenc
lgml
tunicamycin
lack
infect
hemagglutin
activ
tabl
extracellular
viral
particl
devoid
type
surfac
project
fig
c
cultiv
presenc
sodium
monensin
concentr
gm
neither
affect
virul
viru
chang
morpholog
extracellular
progeni
viral
particl
data
shown
purifi
viral
prepar
analyz
togeth
viru
untreat
cell
cultur
sdspage
nonreduc
condit
western
immunoblot
fig
result
indic
high
molwt
structur
glycoprotein
could
longer
detect
follow
tunicamycin
treatment
tcvinfect
cell
speci
still
resolv
gel
silver
stain
autoradiograph
immunoprecipit
fig
slightli
higher
mobil
longer
detect
western
immunoblot
fig
concomit
decreas
amount
speci
note
assay
tissu
cultureadapt
minnesota
strain
tcv
grown
presenc
radiolabel
amino
acid
glucosamin
purpos
obtain
inform
virion
structur
protein
structur
natur
polypeptid
resolv
sdspage
purifi
viru
confirm
western
immunoblot
immunoprecipit
experi
use
antitcv
hyperimmun
serum
previous
obtain
immun
rabbit
origin
eggadapt
viru
four
major
viral
protein
speci
identifi
locat
virion
deduc
digest
studi
use
variou
proteolyt
enzym
tcv
structur
protein
consist
three
glycoprotein
shown
correspond
peplom
hemagglutinin
matrix
protein
predomin
unglycosyl
speci
appar
repres
nucleocapsid
protein
similar
polypeptid
pattern
describ
previous
viru
purifi
intestin
content
turkey
embryo
polypeptid
speci
earlier
identifi
probabl
hostcel
contamin
protein
degrad
product
viral
compon
result
digest
intestin
proteas
largest
virion
glycoprotein
tcv
thu
appear
differ
fundament
largest
glycoprotein
wellcharacter
avian
infecti
bronchiti
viru
ibv
antigen
unrel
coronaviru
presenc
addit
short
granular
project
surfac
tcv
virion
hemagglutinin
glycoprotein
dea
et
al
appear
dimer
two
smaller
molecul
featur
describ
far
virus
belong
group
mammalian
hemagglutin
coronavirus
studi
show
virion
k
peplom
glycoprotein
tcv
like
k
speci
mhv
bcv
ibv
possess
trypsin
sensit
site
cleavag
yield
two
subunit
appar
molwt
k
k
glycosyl
speci
molwt
excess
k
probabl
correspond
multimer
form
peplomer
glycoprotein
previous
describ
human
strain
bcv
ibv
proteolyt
cleavag
tcv
peplom
protein
appear
occur
quit
effici
gp
gp
predomin
form
resolv
sdspage
also
appear
true
bcv
hcv
degre
posttransl
cleavag
strain
found
function
host
cell
type
although
investig
suscept
tcv
differ
cell
type
previous
found
viru
could
induc
polykaryocytosi
cell
trypsin
ad
mainten
medium
addit
trypsin
medium
tcvinfect
primari
chicken
turkey
embryo
kidney
cell
line
permit
express
cytopathogen
viru
trypsin
cleavag
tcv
seem
thu
necessari
acquisit
fusion
activ
therefor
infect
viru
host
cell
intrins
factor
probabl
also
involv
similar
find
observ
mhv
bcv
sever
strain
ibv
form
plaqu
unless
trypsin
ad
overlay
medium
treatment
differ
proteas
remov
extern
protein
tcv
show
bromelain
trypsinand
chymotrypsintr
viru
still
hemagglutin
rat
erythrocyt
wherea
pronas
complet
destroy
activ
observ
bromelain
treatment
remov
glycoprotein
virion
except
gp
small
granular
project
retain
particl
ghostlik
structur
tcv
subject
long
exposur
strongli
suggest
gp
small
granular
project
correspond
virion
hemagglutinin
associ
small
granular
project
hemagglutinin
also
demonstr
case
mammalian
hemagglutin
coronavirus
pronas
bromelain
also
reduc
amount
antigen
similar
find
coronavirus
enzym
may
remov
portion
correspond
termin
glycosyl
region
matrix
protein
expos
outer
surfac
viral
envelop
larger
nonglycosyl
region
protect
within
envelop
disappear
gel
follow
digest
pronas
bromelain
concomit
reduct
amount
suggest
close
relationship
two
viral
compon
speci
may
repres
dimer
matrix
protein
demonstr
bcv
hcv
similarli
unglycosyl
polypeptid
occasion
reveal
western
immunoblot
immunoprecipit
may
correspond
polym
possibl
trimer
nucleocapsid
protein
suggest
bcv
hcv
basi
reactiv
antin
antibodi
presenc
tm
noninfecti
tcv
virion
lack
type
surfac
peplom
produc
releas
infect
cell
biochem
data
confirm
absenc
high
molwt
glycoprotein
gp
consist
glycosyl
process
involv
attach
oligosaccharid
side
chain
via
nglycosid
bond
asparagin
residu
demonstr
coronavirus
matrix
protein
tcv
appar
glycosyl
similar
process
follow
cultiv
presenc
tm
fail
react
antitcv
serum
western
immunoblot
slightli
higher
mobil
demonstr
immunoprecipit
find
present
immunoprecipit
western
immunoblot
fig
may
explain
nonspecif
coprecipit
antiserum
viral
protein
high
mutual
affin
contrast
western
immunoblot
visibl
protein
individu
immunoreact
ie
suffici
amount
suitabl
conform
epitop
inhibit
glycosyl
matrix
protein
also
suggest
disappear
respect
tcv
resembl
avian
infecti
bronchiti
viru
differ
mammalian
coronavirus
mhva
bcv
analog
protein
mammalian
coronavirus
undergo
olink
glycosyl
process
resist
tm
involv
attach
oligosaccharid
serin
residu
presenc
inner
fold
viral
envelop
could
evagin
follow
trypsin
treatment
devoid
characterist
project
presenc
intern
tonguelik
structur
agreement
structur
model
coronaviru
propos
almeida
bingham
structur
seen
insid
outer
envelop
evagin
breakdown
inner
membran
denser
structur
exist
insid
intact
viral
particl
fig
whether
structur
repres
nucleocapsid
tcv
remain
demonstr
